These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond. Kirchengast M J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195 [TBL] [Abstract][Full Text] [Related]
25. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy. Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931 [TBL] [Abstract][Full Text] [Related]
26. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients. Langtry HD; Markham A Drugs Aging; 1997 Feb; 10(2):131-66. PubMed ID: 9061270 [TBL] [Abstract][Full Text] [Related]
27. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus. Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379 [TBL] [Abstract][Full Text] [Related]
28. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril. Waeber B; Weidmann P; Wohler D; Le Bloch Y Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894 [TBL] [Abstract][Full Text] [Related]
29. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects. Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397 [TBL] [Abstract][Full Text] [Related]
30. [Cardio-Nephroprotection--the Most Important Goal of Antihypertensive Therapy in Patients With Type 2 Diabetes]. Statsenko ME; Derevyanchenko MV Kardiologiia; 2015; 55(8):43-8. PubMed ID: 26761971 [TBL] [Abstract][Full Text] [Related]
31. The effects of lisinopril on renal function in proteinuric renal transplant recipients. Traindl O; Falger S; Reading S; Banyai M; Liebisch B; Gisinger J; Templ E; Mayer G; Kovarik J Transplantation; 1993 Jun; 55(6):1309-13. PubMed ID: 8390733 [TBL] [Abstract][Full Text] [Related]
32. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199 [TBL] [Abstract][Full Text] [Related]
33. A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension. Samuelsson O; Hedner T; Ljungman S; Herlitz H; Widgren B; Pennert K Eur J Clin Pharmacol; 1992; 43(5):469-75. PubMed ID: 1336463 [TBL] [Abstract][Full Text] [Related]
34. Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure. August P; Lenz T; Laragh JH Am J Hypertens; 1993 Apr; 6(4):148S-154S. PubMed ID: 8389563 [TBL] [Abstract][Full Text] [Related]
35. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure. Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Kleinbloesem CH; Huysmans FT J Cardiovasc Pharmacol; 1990 Dec; 16(6):924-30. PubMed ID: 1704985 [TBL] [Abstract][Full Text] [Related]
36. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy. Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100 [TBL] [Abstract][Full Text] [Related]
37. The benefits of ACE inhibitors and calcium antagonists in slowing progressive renal failure: focus on fixed-dose combination antihypertensive therapy. Epstein M Ren Fail; 1996 Nov; 18(6):813-32. PubMed ID: 8948517 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study. O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924 [TBL] [Abstract][Full Text] [Related]
39. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial. Fernandez Juarez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Cachofeiro V; Nieto J; Fernández Vega F; Tato A; Gutierrez E; Am J Kidney Dis; 2013 Feb; 61(2):211-8. PubMed ID: 22939518 [TBL] [Abstract][Full Text] [Related]
40. Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial. Schram MT; van Ittersum FJ; Spoelstra-de Man A; van Dijk RA; Schalkwijk CG; Ijzerman RG; Twisk JW; Stehouwer CD J Hum Hypertens; 2005 Jun; 19(6):429-37. PubMed ID: 15647778 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]